Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gurioli

Showing results (271-280 of 316) with videos related to

Pageof 32
Sort By:
World Journal of Urology|December 3, 2017
How to accelerate the upper urinary stone discharge after extracorporeal shockwave lithotripsy (ESWL) for < 15 mm upper urinary stones: a prospective multi-center randomized controlled trial about external physical vibration lithecbole (EPVL)Wenqi Wu, Zhou Yang, Fengling Tang, et al.
British Journal of Cancer|August 1, 2021
Circulating androgen receptor gene amplification and resistance to <sup>177</sup>Lu-PSMA-617 in metastatic castration-resistant prostate cancer: results of a Phase 2 trialUgo De Giorgi, Maddalena Sansovini, Stefano Severi, et al.
BMJ Open|December 8, 2025
Matrix-directed therapy losartan to identify the effect on the bone resorption marker carboxy-terminal crosslink of type I collagen telopeptide (CTX) in older adolescents and adults with osteogenesis imperfecta recruited from secondary care sites: the 'MOI-A' study; a randomised, phase 2/pilot, dose-escalating trialMahboobeh Haji Sadeghi, Judith Cohen, Bronwen Williams, et al.
Frontiers in Oncology|September 4, 2023
Impact of the time interval between primary or interval surgery and adjuvant chemotherapy in ovarian cancer patientsAlberto Farolfi, Elisabetta Petracci, Giorgia Gurioli, et al.
Cancers|November 7, 2019
Plasma Androgen Receptor in Prostate CancerVincenza Conteduca, Giorgia Gurioli, Nicole Brighi, et al.
International Journal of Molecular Sciences|December 23, 2022
Clinical Impact of Next-Generation Sequencing Multi-Gene Panel Highlighting the Landscape of Germline Alterations in Ovarian Cancer PatientsGiorgia Gurioli, Gianluca Tedaldi, Alberto Farolfi, et al.
BMC Cancer|December 21, 2018
Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancerVincenza Conteduca, Giorgia Gurioli, Lorena Rossi, et al.
Cancers|January 21, 2023
Serum Mass Spectrometry Proteomics and Protein Set Identification in Response to FOLFOX-4 in Drug-Resistant Ovarian CarcinomaDomenico D'Arca, Leda Severi, Stefania Ferrari, et al.
American Journal of Respiratory and Critical Care Medicine|November 13, 2015
Bronchoscopic Lung Cryobiopsy Increases Diagnostic Confidence in the Multidisciplinary Diagnosis of Idiopathic Pulmonary FibrosisSara Tomassetti, Athol U Wells, Ulrich Costabel, et al.
Journal of the American Academy of Dermatology|July 24, 2024
Effective response to upadacitinib in patients affected by prurigo nodularis and by atopic dermatitis with a predominant prurigo nodularis pattern: A multicenter case series studyElena Pezzolo, Alessandra Narcisi, Luigi Gargiulo, et al.
Pageof 32

Showing results (271-280 of 316) with videos related to

Sort By:
Pageof 32
World Journal of Urology|December 3, 2017
How to accelerate the upper urinary stone discharge after extracorporeal shockwave lithotripsy (ESWL) for < 15 mm upper urinary stones: a prospective multi-center randomized controlled trial about external physical vibration lithecbole (EPVL)Wenqi Wu, Zhou Yang, Fengling Tang, et al.
British Journal of Cancer|August 1, 2021
Circulating androgen receptor gene amplification and resistance to <sup>177</sup>Lu-PSMA-617 in metastatic castration-resistant prostate cancer: results of a Phase 2 trialUgo De Giorgi, Maddalena Sansovini, Stefano Severi, et al.
BMJ Open|December 8, 2025
Matrix-directed therapy losartan to identify the effect on the bone resorption marker carboxy-terminal crosslink of type I collagen telopeptide (CTX) in older adolescents and adults with osteogenesis imperfecta recruited from secondary care sites: the 'MOI-A' study; a randomised, phase 2/pilot, dose-escalating trialMahboobeh Haji Sadeghi, Judith Cohen, Bronwen Williams, et al.
Frontiers in Oncology|September 4, 2023
Impact of the time interval between primary or interval surgery and adjuvant chemotherapy in ovarian cancer patientsAlberto Farolfi, Elisabetta Petracci, Giorgia Gurioli, et al.
Cancers|November 7, 2019
Plasma Androgen Receptor in Prostate CancerVincenza Conteduca, Giorgia Gurioli, Nicole Brighi, et al.
International Journal of Molecular Sciences|December 23, 2022
Clinical Impact of Next-Generation Sequencing Multi-Gene Panel Highlighting the Landscape of Germline Alterations in Ovarian Cancer PatientsGiorgia Gurioli, Gianluca Tedaldi, Alberto Farolfi, et al.
BMC Cancer|December 21, 2018
Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancerVincenza Conteduca, Giorgia Gurioli, Lorena Rossi, et al.
Cancers|January 21, 2023
Serum Mass Spectrometry Proteomics and Protein Set Identification in Response to FOLFOX-4 in Drug-Resistant Ovarian CarcinomaDomenico D'Arca, Leda Severi, Stefania Ferrari, et al.
American Journal of Respiratory and Critical Care Medicine|November 13, 2015
Bronchoscopic Lung Cryobiopsy Increases Diagnostic Confidence in the Multidisciplinary Diagnosis of Idiopathic Pulmonary FibrosisSara Tomassetti, Athol U Wells, Ulrich Costabel, et al.
Journal of the American Academy of Dermatology|July 24, 2024
Effective response to upadacitinib in patients affected by prurigo nodularis and by atopic dermatitis with a predominant prurigo nodularis pattern: A multicenter case series studyElena Pezzolo, Alessandra Narcisi, Luigi Gargiulo, et al.
Pageof 32